Genzyme, Epizyme, & Rib-X Among the Week’s Life Sciences Newsmakers

Erin Kutz We’ve seen clinical trial, funding, partnership, and IPO news from local drug developers this week. —Genzyme, the Cambridge, MA-based unit of Sanofi (NYSE: SNY) shared more pos…
Read the full story: Xconomy Life Sciences